Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: EPIBONE, INC.
Awarding agency: Department of Defense / Department of the Air Force
Funding agency: Department of Defense / Department of the Air Force
Period of performance: 2025-08-28 to 2027-06-01
Current total value of award: $1249964
Description: REGENERATING WARFIGHTER MOBILITY WITH EB-OC- A NEXT-GENERATION LIVING OSTEOCHONDRAL GRAFT TO TREAT COMBAT-ACQUIRED OSTEOARTHRITIS